Radioprotection and Radiomitigation: From the Bench to Clinical Practice
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The development of protective agents against harmful radiations has been a subject of investigation for decades. However, effective (ideal) radioprotectors and radiomitigators remain an unsolved problem. Because ionizing radiation-induced cellular damage is primarily attributed to free radicals, radical scavengers are promising as potential radioprotectors. Early development of such agents focused on thiol synthetic compounds, e.g., amifostine (2-(3-aminopropylamino) ethylsulfanylphosphonic acid), approved as a radioprotector by the Food and Drug Administration (FDA, USA) but for limited clinical indications and not for nonclinical uses. To date, no new chemical entity has been approved by the FDA as a radiation countermeasure for acute radiation syndrome (ARS). All FDA-approved radiation countermeasures (filgrastim, a recombinant DNA form of the naturally occurring granulocyte colony-stimulating factor, G-CSF; pegfilgrastim, a PEGylated form of the recombinant human G-CSF; sargramostim, a recombinant granulocyte macrophage colony-stimulating factor, GM-CSF) are classified as radiomitigators. No radioprotector that can be administered prior to exposure has been approved for ARS. This differentiates radioprotectors (reduce direct damage caused by radiation) and radiomitigators (minimize toxicity even after radiation has been delivered). Molecules under development with the aim of reaching clinical practice and other nonclinical applications are discussed. Assays to evaluate the biological effects of ionizing radiations are also analyzed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polyphenols: Food sources and bioavailability
Manach, C., Scalbert, A., Morand, C., Rémésy, C., & Jiménez, L. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.5.727 · Cited by 8,175
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061
Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance
Bravo, L. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1998.tb01670.x · Cited by 4,030 · cited 2×
“Their primary role is to protect plants from any type of stress, such as ultraviolet (UV) radiation, pathogens aggression, low fertility in the soil, too elevated or too low temperatures, severe drought, and grazing pressure [57,58].”
BackgroundStewart, F. A., Akleyev, A. V., Hauer-Jensen, M., Hendry, J. H., Kleiman, N. J., MacVittie, T. J., Aleman, B. M., Edgar, A. B., Mabuchi, K., Muirhead, C. R., et al. (2012) · Annals of the ICRP · doi:10.1016/j.icrp.2012.02.001 · Cited by 1,604
Radiation-induced fibrosis: mechanisms and implications for therapy
Straub, J. M., New, J., Hamilton, C. D., Lominska, C., Shnayder, Y., & Thomas, S. M. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-1974-6 · Cited by 677 · cited 1×
“Another common example is the development of tissue fibrosis (increased collagen synthesis and deposition) that happens in a range of tissues (including subcutaneous tissue, muscle, lung, and the gastrointestinal tract), sometimes a few years after irradiation [33].”
BackgroundRadioprotectors and mitigators of radiation-induced normal tissue injury
Citrin, D., Cotrim, A. P., Hyodo, F., Baum, B. J., Krishna, M. C., & Mitchell, J. B. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-s104 · Cited by 482
Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research
Ivashkevich, A., Redon, C. E., Nakamura, A. J., Martin, R. F., & Martin, O. A. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.12.025 · Cited by 462 · cited 1×
“Furthermore, a phosphorylated form of the H2A histone family member X, γ-H2AX, forms when double-strand breaks appear, and it has been proposed to monitor radiation-induced DNA damage [364].”
BackgroundAn optimized isolation and labeling platform for accurate microRNA expression profiling
SHINGARA, J., KEIGER, K., SHELTON, J., LAOSINCHAI-WOLF, W., POWERS, P., CONRAD, R., BROWN, D., & LABOURIER, E. (2005) · RNA · doi:10.1261/rna.2610405 · Cited by 260
Chainy, G. B., Manna, S. K., Chaturvedi, M. M., & Aggarwal, B. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203614 · Cited by 215
Radiation‐induced tissue damage and response
McBride, W. H., & Schaue, D. (2020) · The Journal of Pathology · doi:10.1002/path.5389 · Cited by 155 · cited 1×
“The effects are usually revealed in a timespan of days to even weeks after the irradiation [27].”
Background
Cited by
Podophyllum hexandrum and its active constituents: Novel radioprotectants
Anand, U., Biswas, P., Kumar, V., Ray, D., Ray, P., Loake, V. I. P., Kandimalla, R., Chaudhary, A., Singh, B., Routhu, N. K., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112555 · Cited by 41
“Along with synthetic compounds, other effective and sustainable radioprotective agents of biological origin are currently being developed [15].”
Background
Metadata
- Authors
- Obrador, E., Salvador, R., Villaescusa, J. I., Soriano, J. M., Estrela, J. M., & Montoro, A.
- Venue
- Biomedicines
- Publisher
- MDPI AG
- Published
- 2020-10-30
- Volume
- 8
- Issue
- 11
- Pages
- 461
- ISSN
- 2227-9059 (ISSN-L)
- OpenAlex
- W3096098211
- Cited by
- 168
- References
- 11
- FWCI
- 8.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Radioprotection and Radiomitigation: From the Bench to Clinical Practice. https://app.cochat.ai/papers/10.3390/biomedicines8110461
- The paper
- Obrador, E., Salvador, R., Villaescusa, J. I., Soriano, J. M., Estrela, J. M., & Montoro, A. (2020). Radioprotection and Radiomitigation: From the Bench to Clinical Practice. Biomedicines. https://doi.org/10.3390/biomedicines8110461
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.